Rosenwald Lindsay A Md - Net Worth and Insider Trading

Rosenwald Lindsay A Md Net Worth

The estimated net worth of Rosenwald Lindsay A Md is at least $20 Million dollars as of 2024-06-09. Rosenwald Lindsay A Md is the Director, 10% Owner of Keryx Biopharmaceuticals Inc and owns about 4,056,649 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $14 Million. Rosenwald Lindsay A Md is the President, CEO & Chairman, 10% Owner of Fortress Biotech Inc and owns about 2,873,905 shares of Fortress Biotech Inc (FBIO) stock worth over $5 Million. Rosenwald Lindsay A Md is also the Director of Journey Medical Corp and owns about 320,715 shares of Journey Medical Corp (DERM) stock worth over $2 Million. Besides these, Rosenwald Lindsay A Md also holds Checkpoint Therapeutics Inc (CKPT) , Mustang Bio Inc (MBIO) , Avenue Therapeutics Inc (ATXI) . Details can be seen in Rosenwald Lindsay A Md's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rosenwald Lindsay A Md has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).

Transaction Summary of Rosenwald Lindsay A Md

Rosenwald Lindsay A Md Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rosenwald Lindsay A Md owns 12 companies in total, including Fortress Biotech Inc (FBIO) , Mustang Bio Inc (MBIO) , and Checkpoint Therapeutics Inc (CKPT) among others .

Click here to see the complete history of Rosenwald Lindsay A Md’s form 4 insider trades.

Insider Ownership Summary of Rosenwald Lindsay A Md

Ticker	Comapny	Transaction Date	Type of Owner
FBIO	Fortress Biotech Inc	2024-05-16	director & 10 percent owner & PRESIDENT & CEO & CHAIRMAN
MBIO	Mustang Bio Inc	2022-09-13	director
CKPT	Checkpoint Therapeutics Inc	2019-11-20	director
		2023-09-08	director
		2016-09-12	10 percent owner
		2016-05-20	director & 10 percent owner & Co-Chairman and CEO
		2007-01-22	10 percent owner
		2006-06-09	director & 10 percent owner
		2005-09-13	10 percent owner
		2003-11-07	10 percent owner
		2004-02-12	10 percent owner
		2024-03-25	director

Rosenwald Lindsay A Md Latest Holdings Summary

Rosenwald Lindsay A Md currently owns a total of 6 stocks. Among these stocks, Rosenwald Lindsay A Md owns 4,056,649 shares of Keryx Biopharmaceuticals Inc (KERX) as of November 23, 2004, with a value of $14 Million and a weighting of 66.76%. Rosenwald Lindsay A Md owns 2,873,905 shares of Fortress Biotech Inc (FBIO) as of May 16, 2024, with a value of $5 Million and a weighting of 25.34%. Rosenwald Lindsay A Md also owns 320,715 shares of Journey Medical Corp (DERM) as of March 25, 2024, with a value of $2 Million and a weighting of 7.38%. The other 3 stocks Checkpoint Therapeutics Inc (CKPT) , Mustang Bio Inc (MBIO) , Avenue Therapeutics Inc (ATXI) have a combined weighting of 0.52% among all his current holdings.

Latest Holdings of Rosenwald Lindsay A Md

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
KERX	Keryx Biopharmaceuticals Inc	2004-11-23	4,056,649	3.36	13,630,341
FBIO	Fortress Biotech Inc	2024-05-16	2,873,905	1.80	5,173,029
DERM	Journey Medical Corp	2024-03-25	320,715	4.70	1,507,361
CKPT	Checkpoint Therapeutics Inc	2019-11-20	23,789	1.89	44,961
MBIO	Mustang Bio Inc	2022-09-13	299,181	0.15	44,428
ATXI	Avenue Therapeutics Inc	2023-09-08	4,724	3.38	15,967

Holding Weightings of Rosenwald Lindsay A Md

Rosenwald Lindsay A Md Form 4 Trading Tracker

According to the SEC Form 4 filings, Rosenwald Lindsay A Md has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 83,300 shares on November 23, 2004, which brought Rosenwald Lindsay A Md around $970,445.

According to the SEC Form 4 filings, Rosenwald Lindsay A Md has made a total of 8 transactions in Fortress Biotech Inc (FBIO) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Fortress Biotech Inc is the acquisition of 10,000 shares on May 16, 2024, which cost Rosenwald Lindsay A Md around $17,600.

According to the SEC Form 4 filings, Rosenwald Lindsay A Md has made a total of 3 transactions in Journey Medical Corp (DERM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Journey Medical Corp is the acquisition of 10,000 shares on March 25, 2024, which cost Rosenwald Lindsay A Md around $30,400.

More details on Rosenwald Lindsay A Md's insider transactions can be found in the Insider Trading History of Rosenwald Lindsay A Md table.

Insider Trading History of Rosenwald Lindsay A Md

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rosenwald Lindsay A Md Trading Performance

GuruFocus tracks the stock performance after each of Rosenwald Lindsay A Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rosenwald Lindsay A Md is 11.42%. GuruFocus also compares Rosenwald Lindsay A Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rosenwald Lindsay A Md within 3 months outperforms 13 times out of 22 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rosenwald Lindsay A Md's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rosenwald Lindsay A Md

Average Return

Average return per transaction

Outperforming Transactions

6 out of 17 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.35
Relative Return to S&P 500(%)	9.78

Rosenwald Lindsay A Md Ownership Network

Ownership Network List of Rosenwald Lindsay A Md

No Data

Ownership Network Relation of Rosenwald Lindsay A Md

Rosenwald Lindsay A Md Owned Company Details

What does Fortress Biotech Inc do?

Who are the key executives at Fortress Biotech Inc?

Rosenwald Lindsay A Md is the director & 10 percent owner & PRESIDENT & CEO & CHAIRMAN of Fortress Biotech Inc. Other key executives at Fortress Biotech Inc include Chief Financial Officer David Jin , Chief Financial Officer Robyn Hunter , and director & 10 percent owner & EXECUTIVE VICE CHAIRMAN Michael S Weiss .

Fortress Biotech Inc (FBIO) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made 4 insider transaction in Fortress Biotech Inc (FBIO) with a net purchase of 1,727,515. Other recent insider transactions involving Fortress Biotech Inc (FBIO) include a net purchase of 147,058 shares made by Michael S Weiss , a net sale of 10,000 shares made by Dov Klein ,

In summary, during the past 3 months, insiders sold 10,000 shares of Fortress Biotech Inc (FBIO) in total and bought 10,000 shares, with a net sale of 0 shares. During the past 18 months, 10,000 shares of Fortress Biotech Inc (FBIO) were sold and 1,781,240 shares were bought by its insiders, resulting in a net purchase of 1,771,240 shares.

Fortress Biotech Inc (FBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fortress Biotech Inc Insider Transactions

No Available Data

What does Mustang Bio Inc do?

Who are the key executives at Mustang Bio Inc?

Rosenwald Lindsay A Md is the director of Mustang Bio Inc. Other key executives at Mustang Bio Inc include 10 percent owner Fortress Biotech, Inc. , director & President and CEO Manuel Md Litchman , and Interim CFO Eliot M Lurier .

Mustang Bio Inc (MBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mustang Bio Inc (MBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mustang Bio Inc (MBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mustang Bio Inc (MBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mustang Bio Inc Insider Transactions

No Available Data

What does Checkpoint Therapeutics Inc do?

Who are the key executives at Checkpoint Therapeutics Inc?

Rosenwald Lindsay A Md is the director of Checkpoint Therapeutics Inc. Other key executives at Checkpoint Therapeutics Inc include See Remarks William Garrett Gray , director & CEO & President and Director Oliviero James F Iii , and 10 percent owner Fortress Biotech, Inc. .

Checkpoint Therapeutics Inc (CKPT) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made no insider transaction in Checkpoint Therapeutics Inc (CKPT). Other recent insider transactions involving Checkpoint Therapeutics Inc (CKPT) include a net sale of 42,903 shares made by Oliviero James F Iii , and a net sale of 16,667 shares made by William Garrett Gray .

In summary, during the past 3 months, insiders sold 0 shares of Checkpoint Therapeutics Inc (CKPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 59,570 shares of Checkpoint Therapeutics Inc (CKPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,570 shares.

Checkpoint Therapeutics Inc (CKPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Checkpoint Therapeutics Inc Insider Transactions

No Available Data

What does Avenue Therapeutics Inc do?

Who are the key executives at Avenue Therapeutics Inc?

Rosenwald Lindsay A Md is the director of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .

Avenue Therapeutics Inc (ATXI) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made 1 insider transaction in Avenue Therapeutics Inc (ATXI) with a net purchase of 348,675. Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,228 shares were bought by its insiders, resulting in a net purchase of 2,001 shares.

Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avenue Therapeutics Inc Insider Transactions

No Available Data

What does National Holdings Corp do?

Who are the key executives at National Holdings Corp?

Rosenwald Lindsay A Md is the 10 percent owner of National Holdings Corp. Other key executives at National Holdings Corp include 10 percent owner Daniel Asher , President and CFO Glenn C. Worman , and Chief Operating Officer John C. Desena .

National Holdings Corp (NHLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of National Holdings Corp (NHLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of National Holdings Corp (NHLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

National Holdings Corp (NHLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

National Holdings Corp Insider Transactions

No Available Data

What does Origo Acquisition Corp do?

Who are the key executives at Origo Acquisition Corp?

Rosenwald Lindsay A Md is the director & 10 percent owner & Co-Chairman and CEO of Origo Acquisition Corp. Other key executives at Origo Acquisition Corp include 10 percent owner Polar Asset Management Partners Inc. , director & 10 percent owner & CEO and President Edward J Fred , and 10 percent owner Fortress Biotech, Inc. .

Origo Acquisition Corp (OACQF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Origo Acquisition Corp (OACQF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Origo Acquisition Corp (OACQF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Origo Acquisition Corp (OACQF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Origo Acquisition Corp Insider Transactions

No Available Data

What does NovaDel Pharma Inc do?

Who are the key executives at NovaDel Pharma Inc?

Rosenwald Lindsay A Md is the 10 percent owner of NovaDel Pharma Inc. Other key executives at NovaDel Pharma Inc include 10 percent owner Jay Moorin , 10 percent owner Proquest Investments Ii Advisors Fund Lp , and 10 percent owner Proquest Investments Ii Lp .

NovaDel Pharma Inc (NVDL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaDel Pharma Inc (NVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaDel Pharma Inc (NVDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaDel Pharma Inc (NVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

NovaDel Pharma Inc Insider Transactions

No Available Data

What does Keryx Biopharmaceuticals Inc do?

Who are the key executives at Keryx Biopharmaceuticals Inc?

Rosenwald Lindsay A Md is the director & 10 percent owner of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , Chief Financial Officer Scott A Holmes , and 10 percent owner Seth A Klarman .

Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Keryx Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Rosenwald Lindsay A Md is the 10 percent owner of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,534 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

What does TG Therapeutics Inc do?

Who are the key executives at TG Therapeutics Inc?

Rosenwald Lindsay A Md is the 10 percent owner of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .

TG Therapeutics Inc (TGTX) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 69,500 shares made by Laurence N Charney , a net sale of 121,514 shares made by Sean A Power , and a net sale of 39,854 shares made by Sagar Lonial .

In summary, during the past 3 months, insiders sold 27,000 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 27,000 shares. During the past 18 months, 230,868 shares of TG Therapeutics Inc (TGTX) were sold and 109,000 shares were bought by its insiders, resulting in a net sale of 121,868 shares.

TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

TG Therapeutics Inc Insider Transactions

No Available Data

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Rosenwald Lindsay A Md is the 10 percent owner of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soligenix Inc Insider Transactions

No Available Data

What does Journey Medical Corp do?

Who are the key executives at Journey Medical Corp?

Rosenwald Lindsay A Md is the director of Journey Medical Corp. Other key executives at Journey Medical Corp include director & President & CEO Claude Maraoui , Interim CFO Joseph Benesch , and Chief Financial Officer De Paolantonio Ernest Robert .

Journey Medical Corp (DERM) Insider Trades Summary

Over the past 18 months, Rosenwald Lindsay A Md made 3 insider transaction in Journey Medical Corp (DERM) with a net purchase of 130,000. Other recent insider transactions involving Journey Medical Corp (DERM) include a net purchase of 40,755 shares made by Jeffrey Paley , a net sale of 29,100 shares made by Claude Maraoui , and a net sale of 9,290 shares made by Joseph Benesch .

In summary, during the past 3 months, insiders sold 0 shares of Journey Medical Corp (DERM) in total and bought 70,000 shares, with a net purchase of 70,000 shares. During the past 18 months, 78,679 shares of Journey Medical Corp (DERM) were sold and 274,044 shares were bought by its insiders, resulting in a net purchase of 195,365 shares.

Journey Medical Corp (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Journey Medical Corp Insider Transactions

No Available Data

Rosenwald Lindsay A Md Mailing Address

Above is the net worth, insider trading, and ownership report for Rosenwald Lindsay A Md. You might contact Rosenwald Lindsay A Md via mailing address: 375 Park Ave, New York Ny 10152.

Discussions on Rosenwald Lindsay A Md

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.